Common Stock, Shares, Outstanding of FENNEC PHARMACEUTICALS INC. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
FENNEC PHARMACEUTICALS INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • FENNEC PHARMACEUTICALS INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 28,062,000, a 2.3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

FENNEC PHARMACEUTICALS INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 28,062,000 +640,000 +2.3% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 27,733,000 +404,000 +1.5% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 27,594,000 +489,000 +1.8% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 27,527,000 +500,000 +1.8% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 27,422,000 +787,000 +3% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 27,329,000 +820,000 +3.1% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 27,105,000 +694,000 +2.6% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 27,027,000 +666,000 +2.5% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 26,635,000 +397,000 +1.5% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 26,509,000 +442,000 +1.7% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 26,411,000 +371,000 +1.4% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 26,361,000 +347,000 +1.3% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 26,238,000 +231,000 +0.89% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 26,067,000 +60,000 +0.23% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 26,040,000 +37,000 +0.14% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 26,014,000 +11,000 +0.04% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 26,007,000 +197,000 +0.76% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 26,007,000 +651,000 +2.6% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 26,003,000 +6,107,000 +31% 31 Mar 2021 10-Q 13 May 2021 2020 Q1
Q4 2020 26,003,000 +6,107,000 +31% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 25,810,000 +5,914,000 +30% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 25,356,000 +5,460,000 +27% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 19,896,000 0 0% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 19,896,000 0 0% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 19,896,000 +792,000 +4.1% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 19,896,000 +1,102,000 +5.9% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 19,896,000 +1,412,000 +7.6% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 19,896,000 +1,485,000 +8.1% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 19,104,000 +3,247,000 +20% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 18,794,000 +3,165,000 +20% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 18,484,000 +4,841,000 +35% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 18,411,000 +4,768,000 +35% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 15,857,000 +15,843,357 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 15,629,000 +1,986,000 +15% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 13,643,000 +2,636,000 +24% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 13,643,000 +2,703,000 +25% 31 Dec 2016 10-K 28 Mar 2018 2017 FY
Q3 2016 13,643* -10,925,357 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 13,643,000 +2,724,000 +25% 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 11,007,000 +10,996,380 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 10,940,000 +347,000 +3.3% 31 Dec 2015 10-K 29 Mar 2017 2016 FY
Q3 2015 10,939,000 +10,929,139 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 10,919,000 +10,889,462 30 Jun 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 10,620* -29,297,380 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 10,593,000 +874,000 +9% 31 Dec 2014 10-K 28 Mar 2016 2015 FY
Q3 2014 9,861* +9,861 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 29,538* +29,538 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 29,308,000 +29,282,842 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 9,719,000 -15,439,000 -61% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 0 -25,158,000 -100% 30 Sep 2013 10-Q 18 Nov 2013 2013 Q3
Q2 2013 0 -25,158,000 -100% 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 25,158* -25,132,842 31 Mar 2013 10-Q 13 May 2013 2013 Q1
Q4 2012 25,158,000 +25,132,842 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 25,158,000 0 0% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 25,158,000 -427,694,000 -94% 30 Jun 2012 10-Q 13 Aug 2012 2012 Q2
Q1 2012 25,158,000 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 25,158* -20,435,842 31 Dec 2011 10-K 01 Apr 2013 2012 FY
Q3 2011 25,158,000 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 452,852,000 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 20,461,000 31 Dec 2010 10-K 27 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.